Plus, Iraq considers drastic changes to family law, and competing energy and climate visions in the U.S. election.
| The impact of federal negotiation of prescription drug prices The Inflation Reduction Act included provisions enabling the secretary of the U.S. Department of Health and Human Services (HHS) to negotiate the prices for certain prescription drugs. Now, nearly a year after HSS announced the 10 drugs selected for the first set of negotiations, 2026 prices have been established. What kind of savings did the process lead to? Anna Anderson-Cook and Richard G. Frank break down the results in a new report. |
A closer look at the data |
The 10 drugs selected for negotiation account for nearly $50.5 billion in gross Part D drug spending and were purchased on behalf of 9.7 million Medicare beneficiaries. |
More research and commentary Iraq considers drastic changes to family law. Earlier this month, the Iraqi parliament held the first reading of a bill amending Iraq’s personal status law, which has been in place since 1959. If passed, these amendments may reinforce sectarian identity and undermine women’s rights in the country, writes Marsin Alshamary. Competing energy and climate visions in the election. On a special Election ’24 episode of The Current, Samantha Gross unpacks the approaches that a Kamala Harris administration or a second Donald Trump administration would take around one of the most important issues of our time. |
| About Brookings The Brookings Institution is a nonprofit organization based in Washington, D.C. Our mission is to conduct in-depth, nonpartisan research to improve policy and governance at local, national, and global levels. If you were forwarded this email, sign up for the Brookings Brief to stay updated on our latest work. |
The conclusions and recommendations of any Brookings publication are solely those of its author(s), and do not reflect the views of the Institution, its management, or its other scholars. |
|
